PAR 6.52% 24.5¢ paradigm biopharmaceuticals limited..

Ann: iPPS Demonstrates Multiple DMOAD Signals in Phase 2 Study, page-222

  1. 205 Posts.
    lightbulb Created with Sketch. 101
    The MPS partnership and commercialization will bring in revenue that may delay or avoid a capital raise at all. Paul spoke at length at the last meeting about the strategy to establish pricing at a higher point and for this to be the lead candidate. it was all about maximising returns and reducing dilution.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.5¢
Change
0.015(6.52%)
Mkt cap ! $85.7M
Open High Low Value Volume
23.0¢ 24.5¢ 23.0¢ $116.0K 491.1K

Buyers (Bids)

No. Vol. Price($)
1 50000 23.5¢
 

Sellers (Offers)

Price($) Vol. No.
24.5¢ 33682 3
View Market Depth
Last trade - 16.10pm 21/06/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.